Snowball logo
logo
CNMD_logo

CONMED Corporation

CNMD โ€ข NYSE
$45.42-$0.71ย  (1.54%)
Estimate
P/E
24.7
EPS
1.84
Beta
0.898
Growth
Revenue, YoY
0.13%
Net income, YoY
7.7%
FCF, YoY
45.96%
Forecast
P/E (FWD)
9.5
EPS (FWD)
4.782
About the company
Ticker
CNMD
ISIN
US2074101013
Country
United States of America
Sector (GICS)
Healthcare
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Frequently asked questions

What sector does CONMED Corporation (CNMD) operate in?

CONMED Corporation belongs to the Healthcare sector and operates in the Medical Devices industry.

What is CONMED Corporation (CNMD) current stock price?

As of the latest data, CONMED Corporation stock price is $45.42, with a previous close of $46.13. CONMED Corporation lost -$0.71 in the last trading session, representing a -1.54% loss.

What is CONMED Corporation (CNMD) current market capitalization?

CONMED Corporation market cap is approximately 1.36 billion.

What is CONMED Corporation (CNMD) Earnings Per Share (EPS)?

The trailing EPS is $1.84, and the forward EPS is $4.78.

What is CONMED Corporation (CNMD) Price-to-Earnings (P/E) ratio?

CONMED Corporation current P/E ratio is 24.68, with a forward P/E of 9.5.

What is CONMED Corporation (CNMD) EBITDA?

CONMED Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 61.28 million.

Does CONMED Corporation (CNMD) pay dividends?

No. CONMED Corporation does not pay a dividend.

How did CONMED Corporation (CNMD) perform in its most recent earnings report?

In the last report (June 30, 2026), CONMED Corporation posted an EPS surprise of 25.45% and a revenue surprise of 1.76%.

What is CONMED Corporation (CNMD) beta (volatility) score?

CONMED Corporation has a beta of 0.898, meaning its volatility is roughly in line with the market.